Dr Reddys Laboratories board recommends final dividend

Dr Reddys Laboratories has informed that the Board of Directors of the Company at its meeting held on May 12, 2016, has recommended a final dividend of Rs 20 (400%) per equity share of Rs 5 face value, for the financial year 2015-16. The dividend on equity shares, if declared by the shareholders at the ensuing Annual General Meeting, will be credited / dispatched on or after August 1, 2016.

The above information is a part of company’s filings submitted to BSE.